Evidence map›Paper›PMID 34420880›Full record

ArticleTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2021

Alloimmunization in transfused patients with constitutional anemias in Norway.

May Tove Furuseth, Charlotte Alme, Liv Jorunn Garvik, Marit Hellebostad, Anne Grete Bechensteen, Çiğdem Akalın Akkök

Abstract read
PubMed Publisher
In one paragraph

Article in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

May Tove FurusethDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Ullevaal, Oslo, Norway; Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.
Charlotte AlmeDepartment of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Liv Jorunn GarvikDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Ullevaal, Oslo, Norway.
Marit HellebostadDepartment of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Anne Grete BechensteenDepartment of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
Çiğdem Akalın AkkökDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, Ullevaal, Oslo, Norway. Electronic address: uxciak@ous-hf.no.
Oslo University Hospital · NOOsloMet – Oslo Metropolitan University · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe status of red blood cell alloimmunization in patients with constitutional anemias including hemoglobinopathies is not known in Norway. The study objective was to investigate the impact of a strategy based on phenotype-matching for C, c, E, e, K, Jka, Jkb, Fya, Fyb, S and s on alloimmunization. MATERIALS AND

methodsWe reviewed transfusions of 40 patients retrospectively using the computerized blood bank management system and medical records; including diagnosis, age at start of transfusion therapy, gender, number and age of packed red blood cell units transfused, follow-up time, phenotypes of the donors and patients, antigen-negative patients exposed to antigen-positive packed red blood cell units, transfusion reactions and alloantibody specificities.

resultsForty patients received 5402 packed red blood cell units. Alloimmunization frequency was 20 % for the whole group, being 7%, 25 % and 30 % in patients with sickle cell disease (n = 14), thalassemia (n = 16) and other conditions (n = 10), respectively. The alloantibodies detected were anti-E, -c, -C, -Cw, -K, -Jka and -Lua.

conclusionGood communication between the clinicians and the transfusion services is essential for successful management of patients with constitutional anemias. Providing full phenotype-matched units was not always possible. Extended pheno-/genotyping before the first transfusion and providing antigen-negative units for antigen-negative patients for at least C, c, E and K in every red cell transfusion would probably have reduced the alloimmunization rate. Non-phenotype-matched transfusions seem to be the main reason for alloimmunization. Finding markers for identifying responders prone to alloimmunization will ensure targeted transfusion strategies.

Indexed as

AdolescentAdultAnemia, Diamond-BlackfanAnemia, Sickle CellBlood Group AntigensBlood TransfusionChildErythrocytesErythrocyte TransfusionFanconi AnemiaFemaleGenotypeHumansIsoantibodiesMaleNorwayBlood Group AntigensIsoantibodiesAlloimmunizationBlood transfusionSickle cell diseaseThalassemia

Identifiers

PMID34420880
OpenAlexW3195755735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.